Health
A target for potential cancer drugs may, in fact, worsen disease – EurekAlert
Researchers reveal a previously unrealized complexity in cancer development, one that raises concerns and caution about targeting…
In recent years, much scientific effort and funding has focused on developing drugs that target an enzyme with the unwieldy name of Src homology 2-containing protein tyrosine phosphatase 2 or more briefly, Shp2.
Shp2 is a phosphotyrosine phosphatase; its…
Continue Reading
-
Business21 hours agoCould a small investor today match the historic returns of Warren Buffett?
-
General15 hours agoMan charged with murder after alleged assault victim dies in Hervey Bay
-
General16 hours agoGrieving Bunbury family outraged over plan to remove roadside memorial
-
General10 hours agoTaylor Swift breaks Adele’s record for most album sales in first week